Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innospec (IOSP) Current Deferred Revenue (2016 - 2017)

Historic Current Deferred Revenue for Innospec (IOSP) over the last 9 years, with Q4 2017 value amounting to $100000.0.

  • Innospec's Current Deferred Revenue changed 0.0% to $100000.0 in Q4 2017 from the same period last year, while for Dec 2017 it was $100000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $100000.0 for FY2017, which is 0.0% changed from last year.
  • Per Innospec's latest filing, its Current Deferred Revenue stood at $100000.0 for Q4 2017, which was down 0.0% from $100000.0 recorded in Q3 2017.
  • Innospec's 5-year Current Deferred Revenue high stood at $300000.0 for Q4 2013, and its period low was $100000.0 during Q1 2013.
  • Over the past 5 years, Innospec's median Current Deferred Revenue value was $200000.0 (recorded in 2014), while the average stood at $175000.0.
  • As far as peak fluctuations go, Innospec's Current Deferred Revenue tumbled by 9545.45% in 2013, and later soared by 20000.0% in 2014.
  • Innospec's Current Deferred Revenue (Quarter) stood at $300000.0 in 2013, then crashed by 33.33% to $200000.0 in 2014, then changed by 0.0% to $200000.0 in 2015, then tumbled by 50.0% to $100000.0 in 2016, then changed by 0.0% to $100000.0 in 2017.
  • Its Current Deferred Revenue was $100000.0 in Q4 2017, compared to $100000.0 in Q3 2017 and $100000.0 in Q2 2017.